As of November 2024 Novavax has a market cap of €1.32 Billion. This makes Novavax the world's 4908th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 8th, 2024 the market cap of Novavax was reported to be: